Chiesi USA, Inc

Closed
Call
Website
175 Regency Woods Pl
Cary, NC 27518
+1 (919) 678-6611
https://www.chiesiusa.com
Critical Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The company owns rights to the asthma drug ZYFLO, or zileuton tablets, in addition to other formulations of zileuton throughout the world. ZYFLO is one of the only five lipoxygenase inhibitors approved for marketing by the Untied States Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. Critical Therapeutics s commercialization effort for ZYFLO is done with nearly 80 people on the company s specialty sales force. Headquartered in Lexington, Mass., Critical Therapeutics is a privately owned company.

Also at this address

Own this business?
See a problem?

You might also like

Real estate managers, Business services, nec, nec, Services, nec, nec

Mycovia Pharmaceuticals

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.
Drugs and drug proprietaries

Veloxis Pharmaceuticals, Inc

Veloxis Pharmaceuticals, Inc., based in Cary, NC, is a fully integrated specialty pharmaceutical company focused on transforming the future of transplant medicine. As part of the global network of Asahi Kasei, Veloxis is dedicated to developing innovative therapies and programs to support transplant healthcare providers and improve the lives of patients undergoing transplant procedures. With a commitment to agility, efficiency, and responsiveness, Veloxis is leading innovation in the field of transplant medicine. Through partnerships, clinical trials, and community support initiatives, Veloxis is dedicated to addressing the challenges faced by transplant patients and healthcare providers on their journey towards better outcomes and experiences.Generated from the website
Drugs and drug proprietaries

Avior

Avior Bio Inc. is a biopharmaceutical company based in Cary, NC, specializing in the development of therapies for chronic liver disease-associated pruritus and atopic dermatitis-associated pruritus. The company's therapeutic focus lies in addressing these specific conditions through innovative technology and a promising pipeline of treatments, aiming to make a meaningful impact on patients' lives.Generated from the website
United States›North Carolina›Cary›Chiesi USA, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.